Chargement en cours...
Anticoagulation Strategies in Patients With Cancer
Patients with active cancer are at an increased risk of arterial and venous thromboembolism (VTE) and bleeding events. Historically, in patients with cancer, low molecular weight heparins have been preferred for treatment of VTE, whereas warfarin has been the standard anticoagulant for stroke preven...
Enregistré dans:
| Publié dans: | J Am Coll Cardiol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7957366/ https://ncbi.nlm.nih.gov/pubmed/30898209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2019.01.017 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|